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Tuesday, June 1, 2021 
 
 
During this COVID-19 pandemic and other future events, the CDM has been 
and will continue to be a source of reliable information, education and models 
for mitigation, preparedness, response, and recovery.  We hope this 
informational document has helped provide you filtered and actionable 
information.  As the pace of new information and changes occur, we will 
evaluate the current once per week to determine if this information should be 
provided on a more frequent basis.   
 
 
                                                                                                                        
David Markenson, M.D., M.B.A. 
Director 









Worldwide 170,814,464 3,551,884 1,927,961,965 Not Available 
United States 33,266,191 594,603 294,733,321 Not Available 
New Jersey 1,016,332 26,212 9,083,396 14,434,966 
New York 2,102,404 53,303 19,605,540 55,927,263 
Connecticut 347,341 8,238 4,024,797 8,476,087 
 
Information as of 6/1/21 at 1200 EDT. Source: https://coronavirus.jhu.edu/map.html  
 
 






Center for Disaster Medicine Updates 
 
●  On May 11, 2021, CDM conducted a Stop the Bleed training to various medical and public 
safety agencies in the region in order to better prepare them for disasters 
●  Coordinating and overseeing COVID-19 screenings at NYMC campus 
●  Continue to partner with local organizations such as Westchester Department of 
Emergency Services and Westchester Medical Center to ensure ongoing collaboration with 
all public safety agencies. 
●  Coordinating volunteers to support local public health response to COVID-19. 
●  Conducting research and analysis of current events and COVID-19 response to identify 
strengths and areas for improvement in other regions. 
●  Updating and developing new programs to provide enhanced education on public health 
emergencies including pandemics. 
●  Exploring course development opportunities in infection prevention and control for 
frontline responders in the hospital and in the field. 
●  Serving as a source of information for COVID-19 related concerns or questions regarding 
public health, emergency medical service (EMS), public safety and healthcare response.  
●  Local networking and pandemic response analysis for New York’s tri-state area, using 
first-person experiences to highlight current trends. 
 
To view the Center for Disaster Medicine's newest webinar, please click here - The 
COVID-19 Vaccine: What to Tell Your Patients 
 
 
The White House  
 
President Biden issued a press release discussing the investigation into the origins of COVID-
19. He has asked the Intelligence Community to redouble their efforts to collect and analyze 




The official website of the White House will deliver updated information as the country grapples 
with converging crises. This will include actions to control the COVID-19 pandemic, provide 
economic relief, tackle climate change, and advance racial equity and civil rights, as well as 
immediate actions to reform our immigration system and restore America’s standing in the world. 




Health and Human Services (HHS) 
 
Thanks to the American Rescue Plan, the U.S. Department of Health and Human Services 
(HHS), through the Health Resources and Services Administration (HRSA), announced the 
availability of approximately $250 million to develop and support a community-based workforce 
who will serve as trusted voices sharing information about vaccines, increase COVID-19 vaccine 
confidence, and address any barriers to vaccination for individuals living in vulnerable and 




U.S. Health and Human Service (HHS) Secretary Xavier Becerra and U.S. Housing and Urban 
Development (HUD) Secretary Marcia L. Fudge announced a joint-agency effort to increase 
access to COVID-19 prevention and treatment services, including testing and vaccinations, 
among disproportionately affected communities, including among HUD-assisted households and 
people experiencing homelessness. This program will leverage the Health Center COVID-19 
health Vaccine Program which currently provides a direct supply of vaccines to nearly 800 health 
centers across the country. HHS and HUD expect the effort will reach more than 6,000 
multifamily housing properties, 6,700 homeless shelters, and approximately 7,500 public housing 
properties across the country to respond to and stop the spread of COVID-19. 
https://www.hhs.gov/about/news/2021/05/05/hhs-secretary-becerra-hud-secretary-fudge-
announce-joint-effort-increase-access-covid-19-vaccinations.html  
Thanks to the American Rescue Plan, the U.S. Department of Health and Human Services 
(HHS) is announcing the availability of nearly $1 billion to strengthen COVID-19 response efforts 
and increase vaccinations in rural communities. As part of the Biden Administration's 
commitment to expanding access to vaccines and ensuring equity in the COVID-19 response, 
the Health Resources and Services Administration, a part of HHS, will increase the number of 




United States Food and Drug Administration (FDA) 
The U.S. Food and Drug Administration has announced the following actions taken in its 
ongoing response effort to the COVID-19 pandemic: 
• This past week, FDA released the Medical Countermeasures Initiative 
(MCMi) Program Update report which showcases FDA's work each year to 
prepare for all types of public health emergencies, including COVID-19. This 
report, covering fiscal year 2020, includes a snapshot of FDA's COVID-19 
response during the reporting period. 
and work to increase vaccine confidence by empowering trusted local voices with additional 




For the latest COVID-19 information from HHS 
https://www.hhs.gov/about/news/coronavirus/index.html 
 
National Institutes of Health (NIH)  
 
View the latest COVID-19 information from NIH 
https://www.nih.gov/coronavirus 
 
• As part of the FDA’s effort to protect consumers, on May 27, the agency issued 
a warning letter jointly with the Federal Trade Commission to Oclo 
Nanotechnology for selling unapproved chlorine dioxide products with unproven 
COVID-19 claims. FDA continues to warn consumers not to drink chlorine dioxide 
products including “OCLO 3000.” Drinking any chlorine dioxide product can cause 
nausea, vomiting, diarrhea and symptoms of severe dehydration. Consumers 
concerned about COVID-19 should consult with their health care provider. 
• On May 27, 2021, the FDA issued an Update: FDA Recommends Transition from 
Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators - 
Letter to Health Care Personnel and Facilities. The FDA is recommending health 
care personnel and facilities transition away from crisis capacity conservation 
strategies, such as using non-NIOSH-approved disposable respirators, including 
imported respirators such as KN95s. This recommendation is a follow-up to the 
April 9, 2021, letter in which the FDA recommended a transition away from 
decontamination or bioburden-reduction systems for cleaning and disinfecting 
disposable respirators which were being reused by health care personnel. 
• Testing updates: 
o As of 5/28/21, 379 tests and sample collection devices are authorized by 
the FDA under emergency use authorizations (EUAs). These include 274 
molecular tests and sample collection devices, 80 antibody and other 
immune response tests and 25 antigen tests. There are 51 molecular 
authorizations and one antibody authorization that can be used with 
home-collected samples. There is one molecular prescription at-home 
test, two antigen prescription at-home tests, four antigen over-the-counter 
(OTC) at-home tests and two molecular OTC at-home tests. 
o The FDA has authorized nine antigen tests and four molecular tests for 











Centers for Disease Control and Prevention (CDC) 
CDC has updated their COVID-19 vaccine administration and delivery data. You can read 
more about this information at https://covid.cdc.gov/covid-data-tracker/#vaccinations  
CDC provides updated information about the variants in the United States- The emerging 
variants CDC is closely monitoring have mutations in the virus genome that alter the 
characteristics and cause the virus to act differently in ways that are significant to public 
health (e.g., causes more severe disease, spreads more easily between humans, 
requires different treatments, changes the effectiveness of current vaccines). It’s 
important to understand that genetic mutations are expected, and some variants can 
spread and become predominant while others subside. 
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html  
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and 
trends of COVID-19 in the United States- updated daily by 8 pm ET. 
https://covid.cdc.gov/covid-data-tracker/#datatracker-home  




Center for Medicare and Medicaid Services (CMS)   






In this section, vaccine-related information from various sources will be collected, 
reviewed, and tabulated here.  As of June 1, 2021, the FDA has granted Emergency Use 
Authorization (EUA) to Pfizer BioNTech, Moderna and Janssen/Johnson & Johnson. Now 
with three vaccines with EUA, the goal is to vaccinate a larger number of persons in the 
coming months throughout the United States. As additional vaccines are granted EUA, 
information for those vaccines will also be included. 
 
CDC has just published research from the first four months of this year discussing 
breakthrough infections status post vaccine receipt. COVID-19 vaccines are a critical tool 
for controlling the ongoing global pandemic. The Food and Drug Administration (FDA) has 
issued Emergency Use Authorizations for three COVID-19 vaccines for use in the United 
States.* In large, randomized-controlled trials, each vaccine was found to be safe and 
efficacious in preventing symptomatic, laboratory-confirmed COVID-19 (1–3). Despite the 
high level of vaccine efficacy, a small percentage of fully vaccinated persons (i.e. received 
all recommended doses of an FDA-authorized COVID-19 vaccine) will develop 
symptomatic or asymptomatic infections with SARS-CoV-2, the virus that causes COVID-
19 (2–8). https://www.cdc.gov/mmwr/volumes/70/wr/mm7021e3.htm  
 
CDC provides update regarding Possible Side Effects After Getting a COVID-19 Vaccine-
.OVID-19 vaccination will help protect you from getting COVID-19. You may have some 
side effects, which are normal signs that your body is building protection. These side 
effects may affect your ability to do daily activities, but they should go away in a few days. 
Some people have no side effects. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html  
 
CDC releases COVID-19 Vaccine Toolkit for Institutions of Higher Education (IHE), 
Community Colleges, and Technical Schools. More people get vaccinated when they 
have strong confidence in the vaccines within their communities. And more people 
vaccinated leads to fewer COVID-19 illnesses, hospitalizations, and deaths. CDC has 
designed a toolkit to help administrators and staff at institutions of higher education (IHE) 
share clear, complete, and accurate messages about COVID-19 vaccines. These unified 
messages can help build confidence among students and staff and encourage COVID-19 
vaccination among students. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/toolkits/higher-education.html  
 
CDC created this section regarding COVID-19 vaccinations in the United States CDC 
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and 
data updated daily by 8 PM. This section represents all vaccine partners including 
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal 
Emergency Management Agency and Health Resources and Services Administration 
partner sites, and federal entity facilities.  
https://covid.cdc.gov/covid-data-tracker/#vaccinations  
 
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide 
updated relevant information including side effects and safety data, clinical trials 
demographic statistics, and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html  
 
CDC created this section regarding the Moderna vaccine to provide updated relevant 
information including side effects and safety data, clinical trials demographic statistics, 
and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html   
 
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated 
relevant information including side effects and safety data, clinical trials demographic 




HHS created this section to provide the latest information about COVID-19 vaccines. 
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html  
 
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the 
distribution of the vaccine including the number of doses received by the state, a 
breakdown of first or second doses, and the number of persons vaccinated with the first 
and second doses in each region. 
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker  
 
For NYC DOHMH updated guidance regarding COVID-19 vaccine 
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page  
 
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19 
vaccination location. The Vaccine Finder can also provide New Yorkers with information 
to schedule vaccination appointments. 
https://vaccinefinder.nyc.gov/  
 
Educational Institution Information 
• Higher Education 
o Online exam proctoring company ProctorU announced earlier this week 
that it will no longer send artificial intelligence-generated reports of 
potential student misconduct to institutions without ProctorU staff 
members first reviewing the footage -- a development raising more 
questions than it answers about higher education’s use of the technology. 
ProctorU, like many companies offering remote proctoring services, 
employs AI technology to monitor student movement during tests and flag 
activity that might indicate a student is cheating. Typical behavior that 
may be flagged by the AI includes students getting up from their seats, 
not looking consistently at their screens or talking out loud. Previously, as 
part of its cheapest proctoring package, ProctorU sent AI-generated 
incident reports to instructors without staff members reviewing them first. 
The company offered this package on the condition that any AI-generated 
reports would be reviewed by instructors. But that wasn’t happening, said 
Jarrod Morgan, founder and chief strategy officer of ProctorU. 
https://www.insidehighered.com/news/2021/05/28/are-colleges-checking-
ais-work-remote-exam-proctoring  
o Some institutions took the COVID-19 crisis as an “opportunity to 
turbocharge the corporate model,” says a new report from the American 
Association of University Professors. Without declaring financial 
exigency, they laid off faculty members “as expeditiously as if colleges 
and universities were businesses whose CEOs suddenly decided to stop 
making widgets or shut down the steelworks.” This phenomenon isn’t 
unfamiliar to the AAUP. The organization made similar observations 
about certain New Orleans-area institutions following the disaster that 
was Hurricane Katrina. So much so that the AAUP warned early on in the 
pandemic that COVID-19 could erode shared governance, via 





o Though the digital divide was thrust into the spotlight by the COVID-19 
pandemic, the issue has been a persistent and growing equity concern 
dating back several presidential administrations. With an estimated 29 
million U.S. households with school-age children still lacking reliable 
broadband access, the divide is set to remain an issue even as the 
pandemic subsides. How the investments of the past year are sustained 
and capitalized upon, and where future investments are made, will impact 
the nation's educational outcomes for years to come. Our Decoding the 
Divide series highlights specific barriers and solutions to these 








To view the latest information on clinical trials regarding COVID-19 
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=  










• Governor Andrew M. Cuomo announced that the New York State Department of Labor 
is issuing guidance to all employers that any necessary recovery period from the 
COVID-19 vaccine is covered under the state's Paid Sick Leave Law. According to a 
recent survey conducted by the Kaiser Family Foundation, among unvaccinated 
Americans, 48 percent say they are concerned they "might need to miss work if the side 
effects of the vaccine make them feel sick for a day or more." This group includes nearly 
two-thirds, or 64 percent, of unvaccinated Hispanic adults and over half of Black adults, 
or 55 percent. https://www.governor.ny.gov/news/governor-cuomo-announces-new-
guidance-reminding-employers-new-yorks-paid-sick-leave-law-covers  
 
New York State Department of Health (DOH) 
 




NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information 
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down 










• Governor Phil Murphy issued Executive Order No. 243, which rescinds the requirement 
in Executive Order No. 107 that businesses and non-profits accommodate telework 
arrangements for their workforce to the maximum extent practicable and reduce their on-
site staff to the minimal number necessary for their operations.  Employers bringing 
employees back to the physical worksite must continue to follow all applicable portions 
of Executive Order No. 192, including notifying employees of on-site exposure and 
performing health screenings of employees entering the worksite. The Order further 
permits employers in indoor worksites that are closed to the public to allow employees 
who can verify that they are vaccinated the ability to forego wearing a mask and social 
distancing.  Employers retain the ability to issue more restrictive policies on masking and 
social distancing.  Employers shall not restrict individuals from wearing masks and shall 
not penalize or retaliate against individuals who choose to wear a mask. 
https://nj.gov/infobank/eo/056murphy/pdf/EO-243.pdf  
• Governor Murphy today released a report on New Jersey’s response to the opioid 
overdose epidemic during the COVID-19 public health emergency in 2020. The report 
details the overdose mitigation strategies implemented over the course of Governor 
Murphy’s administration that contributed to the resiliency demonstrated during the 
convergence the opioid crisis and the pandemic. Governor Murphy also announced a 
new public data dashboard from the Office of the Chief State Medical Examiner that will 
provide public health partners and law enforcement agencies with near real-time data 
regarding suspected-drug related deaths, enhancing their ability to rapidly address 
potential threats to the community. Given the augmented risk for overdoses during the 
pandemic, New Jersey anticipated a substantial increase in annual drug-related deaths 
last year. Compared to 2019, New Jersey saw a slight increase in drug-related deaths, 
but did not see the anticipated dramatic surge of deaths due to the COVID-19 pandemic 
experienced in many states across the country. New Jersey lost 3,046 lives to 
suspected drug-related deaths in 2020, compared to 3,021 suspected drug-related 
deaths in 2019. The 2019 cases have now been confirmed, the Governor announced, to 
be 2,914 lives lost to drug-related 







Local Updates  
 
New York Blood Center (NYBC) 
 
For the latest updated NYBC information about COVID-19: 
https://nybc.org/covid-19/  
 
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)   
 
For the latest COVID-19 information from NYC DOHMH 
https://www1.nyc.gov/site/doh/covid/covid-19-main.page  
 
Westchester County Department of Health 
 




For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams 
offering earlier access to vaccines. 
https://health.westchestergov.com/2019-novel-coronavirus  
 
Putnam County Department of Health 
Breakdown of positive cases by towns in Putnam County as of May 21, 2021- 
https://www.putnamcountyny.com/covid19/  
 
For the latest COVID-19 information 
https://www.putnamcountyny.com/health/coronavirus/ 
 
Dutchess County Department of Health 
 
Breakdown of positive cases in Dutchess County as of May 24, 2021 
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm 
 
For the latest COVID-19 information: 
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm 
 
Orange County Department of Health   
 
Updated COVID-19 dashboard for Orange County, NY as of May 24, 2021 
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71  
 




Rockland County Department of Health 
 
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of 
May 28, 2021 
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096  
 





For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital 




Center for Disaster Medicine Media 
 
 
New York Medical College Leadership News: 
Westchester High School Students Warming to COVID Vaccine Despite Concerns 
https://www.theexaminernews.com/westchester-high-school-students-warming-to-covid-
vaccine-despite-concerns/ 
The Examiner News 
5/27/21 
Mill Etienne, M.D. '02, M.P.H. FAAN, FAES, vice chancellor for diversity and inclusion, 
associate dean of student affairs and associate professor of neurology and of medicine,  
Faculty News: 





Stephen Ferrando, M.D., Har Esh Professor and Chair of the Department of Psychiatry and 
Behavioral Sciences  
 
 
Every effort is made to provide accurate and complete information in this newsletter. However, New 
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or 
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the 
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of 
this newsletter.  
 
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the 







New York Medical College 
Center for Disaster Medicine 
7 Dana Road Suite 511 
Valhalla, New York 10595 
914-594-1750 
https://www.nymc.edu/center-for-disaster-medicine/ 
 
 
 
 
 
 
